CCSN calls for timely access to targeted bone therapies for patients with advanced prostate cancer in British Columbia

The Canadian Cancer Survivor Network has learned that BC Pharmacare has listed the newest bone-targeting agent on its formulary for men with advanced prostate cancer that has spread to their bones, who are considered palliative. While this is good news for these patients and a positive step forward, other men with prostate cancer that has spread to their bones, who are not palliative, are still being